TetraLogic Pharmaceuticals Corporation
TLOG
$0.00
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | 09/30/2015 | |
|---|---|---|---|---|---|
| Net Income | -40.72M | -42.98M | -48.11M | -49.72M | -47.39M |
| Total Depreciation and Amortization | 152.40K | 191.30K | 217.20K | 187.90K | 181.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.25M | 13.25M | 12.52M | 13.57M | 11.36M |
| Change in Net Operating Assets | 1.43M | 770.50K | 1.69M | 1.08M | -1.16M |
| Cash from Operations | -23.88M | -28.76M | -33.69M | -34.89M | -37.01M |
| Capital Expenditure | -700.00 | -26.90K | -42.90K | -77.40K | -186.40K |
| Sale of Property, Plant, and Equipment | 152.80K | 152.80K | 152.80K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.63M | 22.35M | 28.69M | 35.52M | 34.48M |
| Cash from Investing | 13.78M | 22.48M | 28.80M | 35.45M | 34.29M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -825.00K | -825.00K |
| Issuance of Common Stock | 0.00 | 2.59M | 2.59M | 2.62M | 2.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 2.59M | 2.59M | 1.79M | 1.82M |
| Foreign Exchange rate Adjustments | 78.50K | -58.60K | -129.90K | -119.00K | -216.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.02M | -3.76M | -2.43M | 2.23M | -1.11M |